Max Hodak's Science Corp. is preparing to implant its first neural sensor in a human brain. The device aims to treat neurological conditions through targeted electrical stimulation.
The implantable sensor could help address multiple neurological disorders if clinical trials prove successful. An early application involves delivering gentle electrical stimulation to damaged brain and spinal cord cells to promote healing.
Science Corp., founded by Hodak following his departure from Neuralink, is developing brain-computer interface technology focused on therapeutic applications. The approach differs from consumer-oriented neural interfaces by prioritizing medical outcomes.
The sensor represents a significant step in translating neurotechnology from research settings into clinical practice. Regulatory approval and successful human trials would validate whether electrical stimulation can effectively repair neural tissue and restore function in patients with degenerative conditions.
Details on trial timelines, patient selection criteria, and specific neurological conditions targeted remain limited. The company's progress will likely influence investment and development timelines across the broader neurotech industry.
SK Hynix held a groundbreaking ceremony for a $4 billion advanced memory packaging facility in Indiana. Mass production of next-generation HBM chips is scheduled to begin in the second half of 2029.
Chinese automakers are investing heavily in humanoid robots, following Tesla's lead in betting that the technology represents the next major profit opportunity. Technical advances have triggered a wave of new entrants into the sector.
Yotta Data Services has the capacity to deploy $20 billion in graphics processing units as global demand for AI computing accelerates. The move positions the company to capture a slice of the expanding market for GPU infrastructure.